Matthew Hammond
Partner·RA Capital Management
Matthew Hammond is a Partner at RA Capital Management, where he works on both public and private investments. He serves as a board director for Ambros Therapeutics and previously served on the boards of DTx Pharma, Emergence Therapeutics, Forge Biologics, and Jnana Therapeutics before their respective acquisitions. He also served as CFO and Director of Research Alliance Corp I before its merger with Point Biopharma.
See the rest of Matthew Hammond's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.